Anita Feller

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Predicting 7-Year Survival in Individuals with Chronic Spinal Cord Injury: The Role of Self-Reported Functional Independence, Secondary Health Conditions, Comorbidities, and Health-Related Well-Being.

Predicting 7-Year Survival in Individuals with Chronic Spinal Cord Injury: The Role of Self-Reported Functional Independence, Secondary Health Conditions, Comorbidities, and Health-Related Well-Being.

Journal: Neuroepidemiology

Published: April 28, 2026

Rehabilitation length of stay in individuals with spinal cord injury in Switzerland: A population-based study.

Rehabilitation length of stay in individuals with spinal cord injury in Switzerland: A population-based study.

Journal: The journal of spinal cord medicine

Published: April 13, 2026

Epidemiology and treatment of malignant ovarian germ cell and sex cord stromal tumors in germany: a population-based cancer registry study from 2016 - 2021.

Epidemiology and treatment of malignant ovarian germ cell and sex cord stromal tumors in germany: a population-based cancer registry study from 2016 - 2021.

Journal: Scientific reports

Published: September 15, 2025

Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.

Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.

Journal: JAMA network open

Published: February 16, 2024

A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines.

A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines.

Journal: Swiss medical weekly

Published: July 17, 2023

Predicting the burden of cancer in Switzerland up to 2025.

Predicting the burden of cancer in Switzerland up to 2025.

Journal: PLOS global public health

Published: July 11, 2022

Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017.

Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017.

Journal: Cancers

Published: November 05, 2021

Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study.

Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study.

Journal: Swiss medical weekly

Published: April 01, 2021

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study.

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study.

Journal: Swiss medical weekly

Published: March 11, 2021

Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS).

Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS).

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: July 18, 2020

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Journal: Blood advances

Published: April 24, 2020

Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.

Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.

Journal: Swiss medical weekly

Published: February 08, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026